ArticleCancer management and research2021

Low Dose of Lenvatinib Treatment for Patients of Radioiodine-Refractory Differentiated Thyroid Carcinoma - A Real-World Experience.

He-Jiun Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.